The Inpatient Psychiatric Service has an active research unit that conducts clinical research on major depression, bipolar disorder and schizophrenia. Patients admitted to the inpatient psychiatric service have the opportunity to participate in studies testing novel treatments for psychiatric illnesses. Current research protocols focus on predictors of ECT response, treatment of cognitive side effects of ECT, and treatment of bipolar illness and psychotic depression.
In addition, other research protocols currently underway include a quality management initiative and a collaboration in international mental health. Through these relationships, the IPS hosts a number of international fellows to observe clinical care on the unit.
- The Use of Galantamine in Electroconvulsive Therapy for Mood and Cognitive Functioning
- Combination Therapy with Aripiprazole and Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in the Acute Treatment of Psychotic Major Depressive Disorder: Efficacy and Tolerability
- FDG-Positron Emission Tomography for Predicting Response to Electroconvulsive Therapy in Geriatric Depressed Patients
- An Observational Study of the Effectiveness and Safety of Intramuscular Olanzapine in the Treatment of Agitation in Patients with Schizophrenia or Bipolar Mania
- Comparison Study of the Efficacy and Tolerability Between Depakote ER and Depakote DR in the Acute Treatment of Mania and Mixed Mania